Abeona Therapeutics Inc.ABEONASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank71
3Y CAGR+46.0%
5Y CAGR+22.3%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+46.0%/yr
vs -42.9%/yr prior
5Y CAGR
+22.3%/yr
Recent acceleration
Acceleration
+88.8pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 38.76 | - |
| 2024 | 0.00 | -100.0% |
| 2023 | 28.01 | +124.7% |
| 2022 | 12.46 | +277.2% |
| 2021 | 3.30 | -76.7% |
| 2020 | 14.16 | - |
| 2019 | 0.00 | -100.0% |
| 2018 | 116.94 | -81.2% |
| 2017 | 623.66 | +473.9% |
| 2016 | 108.67 | - |